Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.

about

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.

Item

http://www.wikidata.org/entity/Q53692325

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@en

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@nl

type

Item

label

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@en

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@nl

prefLabel

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@en

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@nl

P1476

Tamoxifen-resistant breast can ...... f upregulated BARD1 and BRCA1.

@en

P2093

Chao Zhang

http://www.w3.org/2001/XMLSchema#string

Dong Yin

http://www.w3.org/2001/XMLSchema#string

Erwei Song

http://www.w3.org/2001/XMLSchema#string

Fengxi Su

http://www.w3.org/2001/XMLSchema#string

Herui Yao

http://www.w3.org/2001/XMLSchema#string

Jianli Zhao

http://www.w3.org/2001/XMLSchema#string

Jieqiong Liu

http://www.w3.org/2001/XMLSchema#string

Junjun Chu

http://www.w3.org/2001/XMLSchema#string

Liang Jin

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

P2860

Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation

Comprehensive molecular portraits of human breast tumours

DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.

Is there more to BARD1 than BRCA1?

The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly

Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.

Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair.

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.

Sox2 promotes tamoxifen resistance in breast cancer cells.

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.

P2888

s41467-018-03951-0

P304

1595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03951-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sol Efroni

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686231

http://www.w3.org/2001/XMLSchema#string

P932

5913295

http://www.w3.org/2001/XMLSchema#string